Free Trial

RxSight (RXST) Stock Price, News & Analysis

RxSight logo
$8.21 -0.07 (-0.85%)
Closing price 04:00 PM Eastern
Extended Trading
$8.26 +0.04 (+0.55%)
As of 06:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About RxSight Stock (NASDAQ:RXST)

Advanced

Key Stats

Today's Range
$8.20
$8.42
50-Day Range
$6.65
$10.02
52-Week Range
$6.32
$55.57
Volume
577,941 shs
Average Volume
1.02 million shs
Market Capitalization
$335.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.00
Consensus Rating
Reduce

Company Overview

RxSight Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
58th Percentile Overall Score

RXST MarketRank™: 

RxSight scored higher than 58% of companies evaluated by MarketBeat, and ranked 635th out of 942 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    RxSight has received a consensus rating of Reduce. The company's average rating score is 1.85, and is based on 1 buy rating, 9 hold ratings, and 3 sell ratings.

  • Upside Potential

    RxSight has a consensus price target of $10.00, representing about 21.8% upside from its current price of $8.21.

  • Amount of Analyst Coverage

    RxSight has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about RxSight's stock forecast and price target.
  • Earnings Growth

    Earnings for RxSight are expected to grow in the coming year, from ($0.70) to ($0.39) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of RxSight is -10.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of RxSight is -10.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    RxSight has a P/B Ratio of 1.18. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about RxSight's valuation and earnings.
  • Percentage of Shares Shorted

    12.75% of the float of RxSight has been sold short.
  • Short Interest Ratio / Days to Cover

    RxSight has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in RxSight has recently decreased by 12.29%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    RxSight does not currently pay a dividend.

  • Dividend Growth

    RxSight does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    12.75% of the float of RxSight has been sold short.
  • Short Interest Ratio / Days to Cover

    RxSight has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in RxSight has recently decreased by 12.29%, indicating that investor sentiment is improving significantly.
    • Insider Buying vs. Insider Selling

      In the past three months, RxSight insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      Only 9.57% of the stock of RxSight is held by insiders.

    • Percentage Held by Institutions

      78.78% of the stock of RxSight is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

    • Read more about RxSight's insider trading history.
    Receive RXST Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for RxSight and its competitors with MarketBeat's FREE daily newsletter.

    By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

    RXST Stock News Headlines

    "I'm risking my reputation on this"
    If I'm right about what's coming, this could be the most important book you'll read this yeartc pixel
    See More Headlines

    RXST Stock Analysis - Frequently Asked Questions

    RxSight's stock was trading at $34.38 on January 1st, 2025. Since then, RXST stock has decreased by 76.1% and is now trading at $8.21.

    RxSight, Inc. (NASDAQ:RXST) posted its quarterly earnings results on Thursday, August, 7th. The company reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.04) by $0.04. RxSight's quarterly revenue was down 3.7% on a year-over-year basis.
    Read the conference call transcript
    .

    RxSight (RXST) raised $125 million in an initial public offering (IPO) on Friday, July 30th 2021. The company issued 7,350,000 shares at $16.00-$18.00 per share.

    Shares of RXST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that RxSight investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), e.l.f. Beauty (ELF), ServiceNow (NOW), Arista Networks (ANET) and Disc Medicine (IRON).

    Company Calendar

    Last Earnings
    8/07/2025
    Today
    10/08/2025
    Next Earnings (Estimated)
    11/06/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    MED INSTRUMENTS
    Sub-Industry
    Medical Equipment
    Current Symbol
    NASDAQ:RXST
    CIK
    1111485
    Fax
    N/A
    Employees
    220
    Year Founded
    1997

    Price Target and Rating

    High Price Target
    $17.00
    Low Price Target
    $8.00
    Potential Upside/Downside
    +21.8%
    Consensus Rating
    Reduce
    Rating Score (0-4)
    1.85
    Research Coverage
    13 Analysts

    Profitability

    EPS (Trailing Twelve Months)
    ($0.80)
    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    -$27.45 million
    Net Margins
    -21.93%
    Pretax Margin
    -21.88%
    Return on Equity
    -11.56%
    Return on Assets
    -10.31%

    Debt

    Debt-to-Equity Ratio
    N/A
    Current Ratio
    13.93
    Quick Ratio
    12.70

    Sales & Book Value

    Annual Sales
    $139.93 million
    Price / Sales
    2.40
    Cash Flow
    N/A
    Price / Cash Flow
    N/A
    Book Value
    $6.98 per share
    Price / Book
    1.18

    Miscellaneous

    Outstanding Shares
    40,920,000
    Free Float
    37,000,000
    Market Cap
    $335.95 million
    Optionable
    Optionable
    Beta
    1.17

    Social Links

    Options Trading Made Easy - Download Now Cover

    Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

    Get This Free Report

    This page (NASDAQ:RXST) was last updated on 10/8/2025 by MarketBeat.com Staff
    From Our Partners